Table:
begin	end	state
1	44	cytoplasmic
45	66	transmembrane
67	78	non-cytoplasmic
79	100	transmembrane
101	106	cytoplasmic
107	127	transmembrane
128	136	non-cytoplasmic
137	156	transmembrane
157	162	cytoplasmic
163	185	transmembrane
186	209	non-cytoplasmic
210	231	transmembrane
232	250	cytoplasmic
251	273	transmembrane
274	296	non-cytoplasmic
297	318	transmembrane
319	350	cytoplasmic
351	370	transmembrane
371	383	non-cytoplasmic
384	412	transmembrane
413	428	cytoplasmic
429	448	transmembrane
449	453	non-cytoplasmic

Input:
>SM_b20903
MAMADITKANQTRADQKPGAQAGRARTTDENPVKRFFRATEIDTRLLGMVGALIIIWLGF
QVMTGGLFDGLFLKPRNLWNLTVQTSSVAVMATGMVLVIVTRNIDLSVGSVLGFCGMIMG
VLQAQVLPQYLGLGHPATWAITLACGIAVGGAIGALHGSIIAFLNVPAFIVTLGGLLVWR
GATWFVTSGQTVAPMDATFRLMGGGTEGSIGATASWIVGSLACIAIVGAILNSRKQRKRF
GFPLRPVWAEYFLSILGCALVLGAVAVANHYYWPVNIARRYADANGIAWPDGGLQISHGI
AIPVLVAIVVGIVMTFIATRLRFGRYVFALGGNPEAAELAGIKTRWVTVKIFTLMGVLCA
IAAAISTARLNAATNAQGELDELYTIAAAVIGGTSLAGGVGTIAGAMIGALVMQSLQSGM
VLLGIDTPFQRIVVGVVLVTAVWLDTVYRARAK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server